| Description | ELISA experiments show that the monoclonal antibody can react with wild RBD protein (WT-RBD), delta variant RBD protein (D-RBD) and Omacron variant (O-RBD) simultaneously. The monoclonal antibody has good neutralizing effects on wild-type (WT), delta (D), BA.1 and BA.2 variants. The antibody has good neutralizing effect on novel coronaviruses of four variants. The neutralization potency is more than 1000 times. |
| Clonality | Monoclonal |
| Host Species | Mouse |
| Target Species | SARS-CoV-2 |
| Cross Reactivity | wt, Delta and Omacron variants |
| Immunogen | Recombinant protein O-RBD |
| Epitope | RBD |
| Affinity | KD=0.117 μM for O-RBD. |
| Isotype | IgG1, κ |
| Expression Species | HEK293F or CHO cell line |
| Conjugation | Unconjugated |
| Purity | >95% |
| Endotoxin | <1 EU/mg |
| Form | Liquid |
| Purification | Protein G purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservative |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
| Application | WB; ELISA; IF; Neut |
| Application Notes | ELISA: 1/1000 |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
